Healthcare

• Conneqt Health (ASX:CQT) sold a record 3,574 CONNEQT Pulse units in the June 2026 quarter, up 33% quarter-on-quarter.

• Ceretas Limited (ASX:CTS) listed on the ASX on 23 July 2026 after an $8 million IPO priced at 25 cents per share, giving an indicative market capitalisation near $18 million.

• Clinuvel Pharmaceuticals (ASX:CUV) is one of very few profitable ASX biotechs, reporting a 20th consecutive half-year profit at the December 2025 half.

• Avecho Biotechnology (ASX:AVE) has reported positive clinical-trial results that the company says support its TPM drug-delivery technology and its cannabidiol (CBD) softgel program.

Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH) closed at AUD 33.02, down 0.15%, on 23 July 2026. The shares declined AUD 0.05 during the session and remain 0.63% lower over the past year, representing a 12-month decrease of AUD 0.21.

Artrya Limited (ASX: AYA) reached another commercialisation milestone on 23 July 2026 after confirming that its Salix artificial-intelligence platform had gone live at Northeast Georgia Health System in the United States.

PYC Therapeutics released an ASX announcement headed "PKD - Safety Committee Approves Dose Escalation" on 22 July 2026, classified as price-sensitive. In substance, the update relayed that an independent safety committee overseeing the company's Phase 1 kidney-disease study had reviewed the trial data available …